Cargando…

Lipocalin‐2 Protects Against Diet‐Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes

Hepatocytes are the major source of hepatic lipocalin‐2 (LCN2), which is up‐regulated in response to inflammation, injury, or metabolic stress. So far, the role of hepatocyte‐derived LCN2 in the development of nonalcoholic fatty liver disease (NAFLD) remains unknown. Herein we show that overexpressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yanyong, Zhu, Yingdong, Jadhav, Kavita, Li, Yuanyuan, Sun, Huihui, Yin, Liya, Kasumov, Takhar, Chen, Xiaoli, Zhang, Yanqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545876/ https://www.ncbi.nlm.nih.gov/pubmed/31168511 http://dx.doi.org/10.1002/hep4.1341

Ejemplares similares

Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
por: Jadhav, Kavita, et al.
Publicado: (2018)

Hepatocyte‐Specific Expression of Human Carboxylesterase 1 Attenuates Diet‐Induced Steatohepatitis and Hyperlipidemia in Mice
por: Xu, Yanyong, et al.
Publicado: (2020)

Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism
por: Xu, Yanyong, et al.
Publicado: (2021)

Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury
por: Xu, Jiesi, et al.
Publicado: (2016)

Hepatic retinoic acid receptor alpha mediates all‐trans retinoic acid's effect on diet‐induced hepatosteatosis
por: Cassim Bawa, Fathima N., et al.
Publicado: (2022)

Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis
por: Zhu, Yingdong, et al.
Publicado: (2023)

Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease
por: Xu, Yanyong, et al.
Publicado: (2021)

Retinoic Acid Receptor Alpha (RARα) in Macrophages Protects from Diet-Induced Atherosclerosis in Mice
por: Cassim Bawa, Fathima N., et al.
Publicado: (2022)

Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
por: Pan, Xiaoli, et al.
Publicado: (2022)

Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr(−/−) mice
por: Xu, Jiesi, et al.
Publicado: (2017)

Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease
por: Cansby, Emmelie, et al.
Publicado: (2018)

Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice
por: Yang, Yan, et al.
Publicado: (2021)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

Diet induces hepatocyte protection in fatty liver disease via modulation of PTEN signaling
por: Ikeda, Yuka, et al.
Publicado: (2020)

Vegetarian diet, food substitution, and nonalcoholic fatty liver
por: Chiu, Tina H., et al.
Publicado: (2018)

Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Chen, Tianyi, et al.
Publicado: (2022)

Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: (2)H(2)O-Metabolic Labeling-Based Kinetic Approach
por: Sadana, Prabodh, et al.
Publicado: (2020)

Foxa1 Reduces Lipid Accumulation in Human Hepatocytes and Is Down-Regulated in Nonalcoholic Fatty Liver
por: Moya, Marta, et al.
Publicado: (2012)

Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
por: Alexopoulos, Anastasia‐Stefania, et al.
Publicado: (2021)

Corrigendum: Vegetarian diet, food substitution, and nonalcoholic fatty liver
Publicado: (2018)

Retraction: Nonalcoholic fatty liver disease, diet and gut microbiota
por: Finelli, Carmine, et al.
Publicado: (2017)

Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis
por: Shu, Yaoling, et al.
Publicado: (2020)

Esculetin Alleviates Nonalcoholic Fatty Liver Disease on High-Cholesterol-Diet-Induced Larval Zebrafish and FFA-Induced BRL-3A Hepatocyte
por: Ma, Ji, et al.
Publicado: (2023)

Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis
por: Fang, Miao, et al.
Publicado: (2020)

Huperzine A attenuates nonalcoholic fatty liver disease by regulating hepatocyte senescence and apoptosis: an in vitro study
por: Hu, Xiao-na, et al.
Publicado: (2018)

Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
por: Kheniser, Karim G., et al.
Publicado: (2020)

Diet-induced metabolic hamster model of nonalcoholic fatty liver disease
por: Bhathena, Jasmine, et al.
Publicado: (2011)

Cisd2 Protects the Liver from Oxidative Stress and Ameliorates Western Diet-Induced Nonalcoholic Fatty Liver Disease
por: Huang, Yi-Long, et al.
Publicado: (2021)

Lipocalin-2 in Fructose-Induced Fatty Liver Disease
por: Lambertz, Jessica, et al.
Publicado: (2017)

Lipocalin-2 Deficiency Impairs Thermogenesis and Potentiates Diet-Induced Insulin Resistance in Mice
por: Guo, Hong, et al.
Publicado: (2010)

Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
por: Kasumov, Takhar, et al.
Publicado: (2015)

The p66shc-mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
por: Zhang, Jing, et al.
Publicado: (2020)

Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice
por: Takahara, Ikuko, et al.
Publicado: (2017)

Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse Model
por: Han, Jia, et al.
Publicado: (2021)

Exercise in mice ameliorates high-fat diet-induced nonalcoholic fatty liver disease by lowering HMGCS2
por: Qian, Xiaoli, et al.
Publicado: (2021)

The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study
por: Tyrovolas, Stefanos, et al.
Publicado: (2019)

Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis
por: Goto, Toshihiro, et al.
Publicado: (2018)

Immunoregulatory Effect of Koumine on Nonalcoholic Fatty Liver Disease Rats
por: Yue, Rongcai, et al.
Publicado: (2019)

Protective effect of whey proteins against nonalcoholic fatty liver in rats
por: Hamad, Essam M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_55647p9nnb48u3m7poi5u9205n